Paperpal Prime Logo

Current Oncology : Impact Factor & More

eISSN: 1718-7729pISSN: 1198-0052
JournalOpen Access

Key Metrics

CiteScore
3.5
Impact Factor
< 5
Scite Index
0.86 5-Year SI
SNIP
1.14
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Oncology

Current Oncology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher MDPI
Language English
Frequency Monthly
Article Processing ChargesCHF 1800
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1994
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Current Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Current Oncology

Pragmatic Management of EGFR-Mutant NSCLC After Progression on Osimertinib: Canadian Expert Perspectives
  • 5 Aug 2026
  • Current Oncology
Management of Advanced Cutaneous Squamous Cell Carcinoma over the Last Decade: A Single-Centre Retrospective Study
  • 27 Jul 2026
  • Current Oncology
Interleukin-1\u03b2 Gene (IL-1B) rs16944 (-511 C > T) Promoter Polymorphism Is Associated with Cutaneous Melanoma Susceptibility, Stage, and Anatomical Localization in a Northern Italian Case\u2013Control Study
  • 22 Jul 2026
  • Current Oncology
Transcriptomic Stratification Reveals an FRS2-Associated, Proliferation-Independent Phenotype in MDM2-High Sarcomas
  • 22 Jul 2026
  • Current Oncology
Real-World Outcomes of Frontline Multimodal Treatment Strategies for Localized Extranodal NK/T-Cell Lymphoma, Nasal Type: A Single-Center Vietnamese Cohort Study
  • 21 Jul 2026
  • Current Oncology
Report from the 27th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Calgary, Alberta, 26\u201327 September 2025: Advances in Colon and Rectal Cancer \u2020
  • 21 Jul 2026
  • Current Oncology
Pragmatic Management of EGFR-Mutant NSCLC After Progression on Osimertinib: Canadian Expert Perspectives
  • 5 Aug 2026
  • Current Oncology
Management of Advanced Cutaneous Squamous Cell Carcinoma over the Last Decade: A Single-Centre Retrospective Study
  • 27 Jul 2026
  • Current Oncology
Interleukin-1\u03b2 Gene (IL-1B) rs16944 (-511 C > T) Promoter Polymorphism Is Associated with Cutaneous Melanoma Susceptibility, Stage, and Anatomical Localization in a Northern Italian Case\u2013Control Study
  • 22 Jul 2026
  • Current Oncology
Transcriptomic Stratification Reveals an FRS2-Associated, Proliferation-Independent Phenotype in MDM2-High Sarcomas
  • 22 Jul 2026
  • Current Oncology
Real-World Outcomes of Frontline Multimodal Treatment Strategies for Localized Extranodal NK/T-Cell Lymphoma, Nasal Type: A Single-Center Vietnamese Cohort Study
  • 21 Jul 2026
  • Current Oncology
Report from the 27th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Calgary, Alberta, 26\u201327 September 2025: Advances in Colon and Rectal Cancer \u2020
  • 21 Jul 2026
  • Current Oncology

FAQs on Current Oncology